Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
NECC is at the center of state and federal investigations after officials determined the facility’s products were linked to a meningitis outbreak killing more than two dozen people and infecting more than 300.
While an inspection of Ameridose is ongoing, preliminary findings by the FDA reveal sterility assurance concerns for products produced at and distributed by Ameridose. Ameridose entered into a voluntary agreement with the Massachusetts Board of Registration in Pharmacy to cease all pharmacy and manufacturing operations on Oct. 10.
The voluntary recall was not issued based on reports of patients with infections from Ameridose products, though healthcare providers are urged to cease use of and return all Ameridose products, which are listed on the company’s website.
More Articles on Patient Safety:
6 Tips for Proper Housekeeping in an Ambulatory Surgery Center
3 Best Practices for Public Reporting of Quality Information
Joint Commission Releases ASC, Office-Based Surgery 2013 Patient Safety Goals
